Application 020031
- Type
- NDA
- Sponsor
- APOTEX TECHNOLOGIES
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | PAXIL | PAROXETINE HYDROCHLORIDE | TABLET;ORAL | EQ 10MG BASE | Yes | No |
| 002 | PAXIL | PAROXETINE HYDROCHLORIDE | TABLET;ORAL | EQ 20MG BASE | Yes | No |
| 003 | PAXIL | PAROXETINE HYDROCHLORIDE | TABLET;ORAL | EQ 30MG BASE | Yes | No |
| 004 | PAXIL | PAROXETINE HYDROCHLORIDE | TABLET;ORAL | EQ 50MG BASE | No | No |
| 005 | PAXIL | PAROXETINE HYDROCHLORIDE | TABLET;ORAL | EQ 40MG BASE | Yes | Yes |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 60505-3663 | PAXIL | paroxetine hydrochloride | Apotex Corp | NDA | Current |
| 60505-3663 | PAXIL | paroxetine hydrochloride | Apotex Corp | NDA | Current |
| 60505-3663 | PAXIL | paroxetine hydrochloride | Apotex Corp | NDA | Current |
| 60505-3664 | PAXIL | paroxetine hydrochloride | Apotex Corp | NDA | Current |
| 60505-3664 | PAXIL | paroxetine hydrochloride | Apotex Corp | NDA | Current |
| 60505-3664 | PAXIL | paroxetine hydrochloride | Apotex Corp | NDA | Current |
| 60505-3665 | PAXIL | paroxetine hydrochloride | Apotex Corp | NDA | Current |
| 60505-3665 | PAXIL | paroxetine hydrochloride | Apotex Corp | NDA | Current |
| 60505-3665 | PAXIL | paroxetine hydrochloride | Apotex Corp | NDA | Current |
| 60505-3666 | PAXIL | paroxetine hydrochloride | Apotex Corp | NDA | Current |
| 60505-3666 | PAXIL | paroxetine hydrochloride | Apotex Corp | NDA | Current |
| 60505-3666 | PAXIL | paroxetine hydrochloride | Apotex Corp | NDA | Current |
| 60505-3666 | PAXIL | paroxetine hydrochloride | Apotex Corp | NDA | Current |
| 60505-4517 | PAXIL | paroxetine hydrochloride | Apotex Corp | NDA | Current |
| 60505-4517 | PAXIL | paroxetine hydrochloride | Apotex Corp | NDA | Current |
| 60505-4517 | PAXIL | paroxetine hydrochloride | Apotex Corp | NDA | Current |
| 60505-4517 | PAXIL | paroxetine hydrochloride | Apotex Corp | NDA | Current |
| 60505-4517 | PAXIL | paroxetine hydrochloride | Apotex Corp | NDA | Current |
| 60505-4518 | PAXIL | paroxetine hydrochloride | Apotex Corp | NDA | Current |
| 60505-4518 | PAXIL | paroxetine hydrochloride | Apotex Corp | NDA | Current |
| 60505-4518 | PAXIL | paroxetine hydrochloride | Apotex Corp | NDA | Current |
| 60505-4518 | PAXIL | paroxetine hydrochloride | Apotex Corp | NDA | Current |
| 60505-4518 | PAXIL | paroxetine hydrochloride | Apotex Corp | NDA | Current |
| 60505-4519 | PAXIL | paroxetine hydrochloride | Apotex Corp | NDA | Current |
| 60505-4519 | PAXIL | paroxetine hydrochloride | Apotex Corp | NDA | Current |
| 60505-4519 | PAXIL | paroxetine hydrochloride | Apotex Corp | NDA | Current |
| 60505-4519 | PAXIL | paroxetine hydrochloride | Apotex Corp | NDA | Current |
| 60505-4519 | PAXIL | paroxetine hydrochloride | Apotex Corp | NDA | Current |
| 60505-4520 | PAXIL | paroxetine hydrochloride | Apotex Corp | NDA | Current |
| 60505-4520 | PAXIL | paroxetine hydrochloride | Apotex Corp | NDA | Current |
| 60505-4520 | PAXIL | paroxetine hydrochloride | Apotex Corp | NDA | Current |
| 60505-4520 | PAXIL | paroxetine hydrochloride | Apotex Corp | NDA | Current |
| 60505-4520 | PAXIL | paroxetine hydrochloride | Apotex Corp | NDA | Current |
| 70518-2500 | PAXIL | paroxetine hydrochloride | REMEDYREPACK INC. | NDA | Current |
| 70518-2636 | PAXIL | paroxetine hydrochloride | REMEDYREPACK INC. | NDA | Current |
| 70518-2636 | PAXIL | paroxetine hydrochloride | REMEDYREPACK INC. | NDA | Current |
| 70518-2636 | PAXIL | paroxetine hydrochloride | REMEDYREPACK INC. | NDA | Current |